Hormone replacement therapy and risk for coronary heart disease Data from the CORA-study -: A case-control study on women with incident coronary heart disease

被引:12
作者
Windler, Eberhard
Zyriax, Birgit-Christiane
Eidenmueller, Britta
Boeing, Heiner
机构
[1] Univ Hamburg Hosp, Ctr Internal Med, D-20246 Hamburg, Germany
[2] German Inst Human Nutr, Dept Epidemiol, D-14558 Bergholz Rehbrucke, Germany
关键词
hormone replacement therapy; postmenopause; postmenopausal women; coronary heart disease; cardiovascular risk; risk factors; cardiovascular protection; prevention;
D O I
10.1016/j.maturitas.2007.01.004
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Hormone replacement therapy (HRT) has been suggested to prevent cardiovascular disease, while some intervention studies have shed doubt on this concept. Thus, uncertainty remains whether current HRT use is beneficial as to cardiovascular disease or may even be harmful. Objectives: This research investigates the association of hormone replacement therapy, risk factors and lifestyle characteristics with the manifestation of coronary heart disease in current HRT users versus never users. Design: The coronary risk factors for atherosclerosis in women study (CORA-study) provide clinical and biochemical parameters and data on lifestyle in 200 consecutive pre- and postmenopausal women with incident coronary heart disease compared to 255 age-matched population-based controls, of which 87.9% were postmenopausal. Results: Significantly more controls than cases used currently HRT for a median of 9.5 years (32.9% versus 20.2%), while 50.0% of cases and 42.5% of controls had never used HRT (p < 0.02). Compared to women who never used HRT, current users ate less meat and sausage, had a significantly lower BMI and waist-to-hip ratio and a lower prevalence of hypertension, insulin resistance and diabetes. However, current users among cases were often smokers and smoked significantly more cigarettes than never users. In a multivariate analysis the risk of current HRT users for coronary artery disease was 57% lower than the risk of never users (odds ratio 0.428, Cl 0.206-0.860, p < 0.02). Adjustment for conventional and dietary risk factors revealed neither current HRT use, nor HRT use combined with smoking as independent risk factors. Conclusions: These data from the CORA-study are not compatible with an adverse impact of hormone replacement therapy on cardiovascular disease, rather support the notion of beneficial effects of HRT on weight, central adiposity, insulin sensitivity and blood pressure. Yet, the data do not support the presumption of a general healthy user effect in women on HRT either. Rather, in some women adverse lifestyle habits, especially intense smoking, appear to counteract possible beneficial effects of HRT. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 27 条
[1]   Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].
Anderson, GL ;
Limacher, M ;
Assaf, AR ;
Bassford, T ;
Beresford, SAA ;
Black, H ;
Bonds, D ;
Brunner, R ;
Brzyski, R ;
Caan, B ;
Chlebowski, R ;
Curb, D ;
Gass, M ;
Hays, J ;
Heiss, G ;
Hendrix, S ;
Howard, BV ;
Hsia, J ;
Hubbell, A ;
Jackson, R ;
Johnson, KC ;
Judd, H ;
Kotchen, JM ;
Kuller, L ;
LaCroix, AZ ;
Lane, D ;
Langer, RD ;
Lasser, N ;
Lewis, CE ;
Manson, J ;
Margolis, K ;
Ockene, J ;
O'Sullivan, MJ ;
Phillips, L ;
Prentice, RL ;
Ritenbaugh, C ;
Robbins, J ;
Rossouw, JE ;
Sarto, G ;
Stefanick, ML ;
Van Horn, L ;
Wactawski-Wende, J ;
Wallace, R ;
Wassertheil-Smoller, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712
[2]   Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project [J].
BohlscheidThomas, S ;
Hoting, I ;
Boeing, H ;
Wahrendorf, J .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1997, 26 :S59-S70
[3]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[4]   Hormone therapy and coronary heart disease: The role of time since menopause and age at hormone initiation [J].
Grodstein, F ;
Manson, JE ;
Stampfer, MJ .
JOURNAL OF WOMENS HEALTH, 2006, 15 (01) :35-44
[5]   Estrogen for women at varying risk of coronary disease [J].
Grodstein, F ;
Stampfer, MJ .
MATURITAS, 1998, 30 (01) :19-26
[6]   Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women [J].
Hulley, S ;
Grady, D ;
Bush, T ;
Furberg, C ;
Herrington, D ;
Riggs, B ;
Vittinghoff, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07) :605-613
[7]   Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease [J].
Humphrey, LL ;
Chan, BKS ;
Sox, HC .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (04) :273-284
[8]   Glycemic effects of postmenopausal hormone therapy: The heart and estrogen/progestin replacement study - A randomized, double-blind, placebo-controlled trial [J].
Kanaya, AM ;
Herrington, D ;
Vittinghoff, E ;
Lin, F ;
Grady, D ;
Bittner, V ;
Cauley, JA ;
Barrett-Connor, E .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (01) :1-9
[9]   Estrogen plus progestin and the risk of coronary heart disease [J].
Manson, JE ;
Hsia, J ;
Johnson, KC ;
Rossouw, JE ;
Assaf, AR ;
Lasser, NL ;
Trevisan, M ;
Black, HR ;
Heckbert, SR ;
Detrano, R ;
Strickland, OL ;
Wong, ND ;
Crouse, JR ;
Stein, E ;
Cushman, M ;
Alving, B ;
Rossouw, JE ;
Pottern, L ;
Ludlam, S ;
McGowan, JA ;
Prentice, R ;
Anderson, G ;
LaCroix, A ;
Patterson, R ;
McTiernan, A ;
Cochrane, B ;
Hunt, J ;
Tinker, L ;
Kooperberg, C ;
McIntosh, M ;
Wang, CY ;
Chen, C ;
Bowen, D ;
Kristal, A ;
Stanford, J ;
Urban, N ;
Weiss, N ;
White, E ;
Shumaker, S ;
Rautaharju, P ;
Prineas, R ;
Naughton, M ;
Stein, E ;
Laskarzewski, P ;
Cummings, S ;
Nevitt, M ;
Dockrell, M ;
Harnack, L ;
Cammarata, F ;
Lindenfelser, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06) :523-534
[10]   Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial [J].
Margolis, KL ;
Bonds, DE ;
Rodabough, RJ ;
Tinker, L ;
Phillips, LS ;
Allen, C ;
Bassford, T ;
Burke, G ;
Torrens, J ;
Howard, BV .
DIABETOLOGIA, 2004, 47 (07) :1175-1187